The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will continue to serve as Chief Scientific ...

BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...

ProFound Therapeutics, a company pioneering the expanded human proteome to develop medicines, has announced a four-year ...

EUROAPI has signed a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, with a simultaneous closing to ...

UI Pharmaceuticals (UIP), a strategic asset of the University of Iowa (UI) College of Pharmacy, has partnered with MimiVax to ...

AAPS has announced the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San ...

Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.